JULY 2024LIFE SCIENCES REVIEW 7THERAPEUTICSDEVELOPING TRANSFORMATIVE TREATMENTS FOR DRUG-RESISTANT CANCERSOur mission is to be the world leader in p27 cancer biology and therapeutics in order to change outcomes for patients with cancers.CONCARLO THERAPEUTICS, INC.Concarlo Therapeutics, Inc., founded in 2017, is a precision oncology company focused on treating cancers with an innovative and pioneering approach to targeting a unique cellular pathway - p27Kip1.ConcarloTherapeutics.comTHERAPEUTICS
< Page 6 | Page 8 >